Efficacy: primary end points (OS and PFS)
tumor, gastric cancer
TUMOR, GASTRIC CANCER
At a median follow-up duration of 13 months, the median OS was longer in the intention-to-treat (ITT) population of the RP group than the P group (10.2 months, 95% CI = 8.2-12.2 ITT, Kaplan-Meier estimates of time to overall survival among advanced gastric cancer patients treated with RP or P.ITT, Kaplan-Meier estimates of time to progression survival among advanced gastric cancer patients treated with RP or P.PP, Kaplan-Meier estimates of time to overall survival among advanced gastric cancer patients treated with RP or P.PP, Kaplan-Meier estimates of time to progression survival among advanced gastric cancer patients treated with RP or P.We did not detect significant differences between different tumor sites and prior chemotherapy; however, in patients with more than two organs involved, the PFS was slightly longer in the RP group than the P group (2.8 months, 95% CI = 2.2-3.5 